Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGE SUMMARY: Burford Capital Adds Independent Directors

Thu, 27th Feb 2020 17:56

(Alliance News) - The following is a round-up of company director and manager changes announced on Thursday and not separately reported by Alliance News:

----------

Burford Capital Ltd - The litigation finance firm adds Christopher Bogart, chief executive officer and a company founder, to the board, as proposed back in January. Also hires Robert Gillespie, most recently director general of the UK Takeover Panel, and John Sievwright, former chief operating officer for International at Merrill Lynch, as independent non-executive directors. Peter Middleton to step down as chair at 2021 annual general meeting, succeeded by Deputy Chair Steve Wilson. Burford said it will continue to refresh its board and expects to add a further independent director prior to the 2021 AGM. The company is seeking a US listing, and it said Thursday that if successful, it will look to add another US director. Burford was the target of a short-selling attack back in August of last year by Muddy Waters Capital LLC, which charged that Burford "is a poor business masquerading as a great one".

----------

OnTheMarket PLC - Property portal hires Rupert Sebag-Montefiore as independent non-executive director. Sebag-Montefiore served as chief executive officer of estate agent Savills PLC's principal UK subsidiary, as well as head of Global Residential.

----------

Laura Ashley Holdings PLC - Chief Executive Officer Kwan Cheong Ng steps down Thursday to become non-executive director. Had been expected to remain an executive director until end of April. Chief Operating Officer Katharine Poulter promoted to CEO.

----------

ConvaTec Group PLC - Hires Brian May as non-executive director from March 2. May was chief financial officer of Bunzl PLC from 2016 to 2019.

----------

RSA Insurance Group PLC - Alastair Barbour plans to step down as non-executive director in early October, having served nine years on the insurer's board. Clare Bousfield joins board on April 1 and will succeed Barbour as chair of audit committee in October.

----------

AFC Energy PLC - Company Secretary Graeme Lewis to become finance director as well.

----------

REACT Group PLC - Appoints Shaun Doak, managing director of REACT Specialist Cleaning Ltd, to board. Gill Leates moves from executive to non-executive chair. Both changes immediate.

----------

Open Orphan PLC - Chief Financial Officer Leo Toole added to board. Toole was interim CFO and then confirm as permanent earlier this month. He is a 20-year pharmaceuticals and medical technology veteran, having held senior finance positions at the US's Procter & Gamble Co and other multinationals.

----------

Frenkel Topping Group PLC - Elaine Cullen-Grant promoted from financial controller to the board as chief financial officer. Cullen-Grant succeeds Stephen Bentley, who retires on March 1.

----------

Dialight PLC - Karen Oliver and Gotthard Haug hired as non-executive directors from April 1. Oliver is former managing director of Johnson Matthey PLC's Chemicals business. Haug is executive chair of electronics repair and service provider Ivy Technology. Steve Good to step down as director from March 31.

----------

Baronsmead Second Venture Trust PLC - Tim Farazmand hired as independent non-executive director from May 1. Was chair of the British Venture Capital Association.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 May 2020 12:03

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

Read more
11 May 2020 09:06

Open Orphan inks contract with Quotient on Covid-19 antibody testing

(Sharecast News) - Pharmaceutical services company Open Orphan's hVIVO subsidiary has entered into an exclusive contract with Quotient to support Covid-19 antibody testing in the UK.

Read more
4 May 2020 16:21

Open Orphan signs ?3.5m deal with US biotech firm

(Sharecast News) - Pharmaceutical services company Open Orphan announced the signing of a new contract with an unnamed US biotechnology company on Monday, for the provision of a respiratory syncytial virus (RSV) human challenge study.

Read more
4 May 2020 14:35

Open Orphan CEO Steps Down; Inks New Challenge Study Contract

Open Orphan CEO Steps Down; Inks New Challenge Study Contract

Read more
23 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

Read more
23 Apr 2020 10:21

Open Orphan begins testing of Covid-19 anti-viral treatment

(Sharecast News) - Pharmaceutical services company Open Orphan said it had started testing an anti-viral drug to treat Covid-19 on behalf of its client Nearmedic International.

Read more
10 Mar 2020 14:48

Open Orphan Notes Publication Of FLU-v Vaccine Study In Journal

Open Orphan Notes Publication Of FLU-v Vaccine Study In Journal

Read more
9 Mar 2020 14:17

Open Orphan Starts On Coronavirus Challenge Study Model

Open Orphan Starts On Coronavirus Challenge Study Model

Read more
6 Mar 2020 15:23

Open Orphan agrees study with European biotech firm

(Sharecast News) - Orphan drugs-focussed pharmaceutical company Open Orphan announced the signing of a new contract with an unnamed European biotechnology firm for the provision of an RSV human challenge study.

Read more
6 Mar 2020 11:57

Open Orphan Inks New Virus Study Contract With Potential Follow-On

Open Orphan Inks New Virus Study Contract With Potential Follow-On

Read more
13 Feb 2020 14:45

Open Orphan Appoints Interim CFO Leo Toole To Permanent Role

Open Orphan Appoints Interim CFO Leo Toole To Permanent Role

Read more
31 Jan 2020 15:39

Open Orphan raising at least ?5m for merger with hVIVO

(Sharecast News) - Pharmaceutical services company Open Orphan announced a fundraising to raise a minimum of £5m before expenses via a conditional placing of new ordinary shares on Friday, at a price of 6.1p each, to institutional and other investors.

Read more
31 Jan 2020 12:39

Open Orphan Raises GBP5.3 Million To Fund hVIVO Synergy Programme

Open Orphan Raises GBP5.3 Million To Fund hVIVO Synergy Programme

Read more
23 Jan 2020 18:32

Open Orphan In Talks With Investors Regarding GBP5 Million Placing

Open Orphan In Talks With Investors Regarding GBP5 Million Placing

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.